B. Scatton
About
B. Scatton is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health.
According to data from OpenAlex, B. Scatton has authored 290 papers receiving a total of 16.5k indexed citations (citations by other indexed papers that have themselves been cited), including 206 papers in Cellular and Molecular Neuroscience, 131 papers in Molecular Biology and 36 papers in Psychiatry and Mental health. Recurrent topics in B. Scatton's work include Neuroscience and Neuropharmacology Research (157 papers), Neurotransmitter Receptor Influence on Behavior (102 papers) and Receptor Mechanisms and Signaling (73 papers). B. Scatton is often cited by papers focused on Neuroscience and Neuropharmacology Research (157 papers), Neurotransmitter Receptor Influence on Behavior (102 papers) and Receptor Mechanisms and Signaling (73 papers). B. Scatton collaborates with scholars based in France, United States and Sweden. B. Scatton's co-authors include Jesús Bénavidès, A Dubois, Christopher Carter, A. Serrano, Dominique Fage, L. Rouquier, Toru Nishikawa, Michel Le Moal, T Dennis and Marc Savasta and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Neuroscience.
In The Last Decade
B. Scatton
286 papers receiving 15.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| B. Scatton France | 73 | 10.4k | 6.0k | 2.6k | 2.6k | 2.2k | 290 | 16.5k | ||
| Jacques Glowinski France | 73 | 12.9k 1.2× | 7.9k 1.3× | 2.9k 1.1× | 2.1k 0.8× | 2.6k 1.2× | 190 | 19.4k | ||
| Robert H. Roth United States | 71 | 12.6k 1.2× | 6.9k 1.1× | 3.8k 1.5× | 2.2k 0.9× | 2.6k 1.2× | 285 | 19.9k | ||
| George R. Breese United States | 71 | 10.8k 1.0× | 6.0k 1.0× | 2.5k 1.0× | 1.7k 0.7× | 2.2k 1.0× | 338 | 18.3k | ||
| J. Głowiński France | 84 | 18.7k 1.8× | 11.6k 1.9× | 3.8k 1.5× | 2.8k 1.1× | 2.9k 1.3× | 444 | 24.8k | ||
| Gavin P. Reynolds United Kingdom | 72 | 7.7k 0.7× | 5.0k 0.8× | 2.4k 0.9× | 2.6k 1.0× | 2.7k 1.2× | 329 | 16.7k | ||
| Menek Goldstein United States | 82 | 15.5k 1.5× | 9.5k 1.6× | 2.5k 1.0× | 3.9k 1.5× | 3.4k 1.6× | 339 | 24.7k | ||
| Piers C. Emson United Kingdom | 65 | 12.5k 1.2× | 8.0k 1.3× | 3.0k 1.2× | 2.7k 1.1× | 3.8k 1.8× | 208 | 19.9k | ||
| Trevor Sharp United Kingdom | 68 | 11.4k 1.1× | 5.5k 0.9× | 3.0k 1.2× | 1.4k 0.6× | 1.4k 0.6× | 264 | 16.2k | ||
| B. Costall United Kingdom | 64 | 8.5k 0.8× | 5.2k 0.9× | 1.7k 0.7× | 1.4k 0.5× | 1.5k 0.7× | 307 | 13.3k | ||
| Assunta Impérato Italy | 46 | 11.8k 1.1× | 6.0k 1.0× | 3.0k 1.2× | 978 0.4× | 1.7k 0.8× | 101 | 15.2k |
Countries citing papers authored by B. Scatton
Since
Specialization
Citations
This map shows the geographic impact of B. Scatton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Scatton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Scatton more than expected).
Fields of papers citing papers by B. Scatton
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by B. Scatton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Scatton. The network helps show where B. Scatton may publish in the future.
Co-authorship network of co-authors of B. Scatton
This figure shows the co-authorship network connecting the top 25 collaborators of B. Scatton. A scholar is included among the top collaborators of B. Scatton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Scatton. B. Scatton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Claustre, Y., Vincent Santucci, I. Bougault, et al.. (2008). Effects of the β3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: Relevance to its antidepressant/anxiolytic-like profile. Neuroscience. 156(2). 353–364.
2.
Bequet, Frédéric, et al.. (2007). CB1 receptor‐mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. European Journal of Neuroscience. 26(12). 3458–3464.
3.
Gal, Claudine Serradeil‐Le, Guy Germain, Charles Advenier, et al.. (2004). SSR126768A (4-Chloro-3-[(3 R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2- oxo-2,3-dihydro-1 H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, Hydrochloride): A New Selective and Orally Active Oxytocin Receptor Antagonist for the Prevention of Preterm Labor. Journal of Pharmacology and Experimental Therapeutics. 309(1). 414–424.
4.
Claustre, Y., Philippe Brun, Christiane Gueudet, et al.. (2003). SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile. Neuropsychopharmacology. 28(12). 2064–2076.
5.
Griebel, Guy, Jacques Simiand, Claudine Serradeil‐Le Gal, et al.. (2002). Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proceedings of the National Academy of Sciences. 99(9). 6370–6375.
6.
Gal, Claudine Serradeil‐Le, Jean Wagnon, Jacques Simiand, et al.. (2002). Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 300(3). 1122–1130.
7.
Scatton, B., Caroline Cohen, Ghislaine Perrault, et al.. (2001). The preclinical pharmacologic profile of tiapride. European Psychiatry. 16(S1). 29s–34S.
8.
Perrault, Ghislaine, et al.. (1997). アミスルプリドの精神薬理学的プロフィール 前シナプス性D 2 /D 3 ドーパミン受容体きっ抗薬活性と辺縁系選択性を有する向精神薬. Journal of Pharmacology and Experimental Therapeutics. 280(1). 73–82.
9.
Perrault, Ghislaine, Rik C. Schoemaker, & B. Scatton. (1996). Place de l'amisulpride dans la classe des neuroleptiques atypiques. 22. 3–8.
10.
Carter, Christopher, H. Poignet, Susanna Carboni, et al.. (1995). Release of spermidine from the rat cortex following permanent middle cerebral artery occlusion. Fundamental and Clinical Pharmacology. 9(2). 129–140.
11.
Scatton, B.. (1994). Excitatory amino acid receptor antagonists: A novel treatment for ischemic cerebrovascular diseases. Life Sciences. 55(25-26). 2115–2124.
12.
Lloyd, Kenneth G., Philippe Pichat, B. Scatton, et al.. (1990). The psychopharmacology of GABA synapses: update 1989. PubMed. 29. 13–28.
13.
Atkinson, Jeffrey, et al.. (1987). Effect of prolonged clonidine treatment and its withdrawal on noradrenaline turnover in the cerebral cortex and medulla oblongata of the spontaneously hypertensive rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 336(1). 77–80.
14.
Fage, Dominique & B. Scatton. (1986). Opposing effects of D-1 and D-2 receptor antagonists on acetylcholine levels in the rat striatum. European Journal of Pharmacology. 129(3). 359–362.
15.
Poirier, Marie‐France, et al.. (1985). Platelet Monoamine Oxidase Activity and Plasma 3,4-Dihydroxy-phenylethylene Glycol Levels during the Menstrual Cycle. Neuropsychobiology. 14(4). 165–169.
16.
MacKenzie, Eric T., Lars Edvinsson, & B. Scatton. (1985). Functional Bases for a Central Serotonergic Involvement in Classic Migraine: A Speculative View. Cephalalgia. 5(2). 69–78.
17.
Dennis, Trevor & B. Scatton. (1982). A radioenzymatic technique for the measurement of free and conjugated 3,4-dihydroxyphenylethyleneglycol in brain tissue and biological fluids. Journal of Neuroscience Methods. 6(4). 369–382.
18.
Scatton, B. & G. Bartholini. (1981). Drug-induced changes of epinephrine turnover in the rat hypothalamus. Life Sciences. 29(11). 1161–1170.
19.
Scatton, B., J. Dedek, & J. Korf. (1978). Dopamine metabolism in the rat retina and brain after acute and repeated treatment with neuroleptics.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19. 373–5.
20.
Tassin, Jean‐Pol, et al.. (1977). Discovery of the mesocortical dopaminergic system: some pharmacological and functional characteristics.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16. 5–12.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jacques Glowinski Breakdown of academic impact, for papers by Robert H. Roth Breakdown of academic impact, for papers by George R. Breese Breakdown of academic impact, for papers by J. Głowiński Breakdown of academic impact, for papers by Gavin P. Reynolds Breakdown of academic impact, for papers by Menek Goldstein Breakdown of academic impact, for papers by Piers C. Emson Breakdown of academic impact, for papers by Trevor Sharp Breakdown of academic impact, for papers by B. Costall Breakdown of academic impact, for papers by Assunta Impérato